美股市场个股详情

CANF Can-Fite BioPharma

添加自选

2.1653
+0.0303+1.42%

交易中 05/14 11:03 (美东)

1080.58万总市值-721市盈率TTM

Can-Fite BioPharma股票讨论区

登录发表评论

Trytosaveabit

05/09 20:25

News

$Can-Fite BioPharma(CANF.US)$ Benzinga· 2 mins ago
Rhe FDA Has Granted Investigational New Drug Clearance For Can-Fite Biopharma's Namodenoson, For Metabolic Dysfunction-Associated Steatohepatitis, Also Known As Non-alcoholic Steatohepatitis, For The Company's Ongoing Phase 2B Study

Jaguar8

05/06 19:28

$Can-Fite BioPharma(CANF.US)$
NEWS
Can-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602

Trytosaveabit

02/28 20:18

Update

$Can-Fite BioPharma(CANF.US)$ Can-Fite BioPharma Announced Notice Of Allowance In Canada For Its Patent Application Regarding Se Of Namodenoson For The Reduction Of Liver Fat In Patients With NASH

JESSE JAMES8832

01/29 20:10

Can-Fite: Top Scientific Journal Published Positive Data from the COMFORT-1 Phase III Psoriasis Study

$Can-Fite BioPharma(CANF.US)$

WillsPTW

2023/12/18 21:05

👀

$Can-Fite BioPharma(CANF.US)$

Trytosaveabit

2023/12/18 20:06

Update

$Can-Fite BioPharma(CANF.US)$ Can-Fite Receives Positive Response From FDA On Pediatric Study Plan For Treatment Of Children Suffering From Psoriasis With Piclidenoson
Moomoo 24/7· 1 min ago

Trytosaveabit

2023/12/04 20:14

Update

$Can-Fite BioPharma(CANF.US)$ Can-Fite Biopharma Has Completed The Design Of Phase 2A Study Protocol For Pancreatic Cancer And Plans To Submit The Protocol Shortly To Ethical Committees For Approval, Study Will Aim To Enroll About 20 Patients To Establish Safety And Clinical Activity